Enhance Genetics Body Building
New posts
Install the app
How to install the app on iOS

Follow along with the video below to see how to install our site as a web app on your home screen.

Note: This feature may not be available in some browsers.


Celldex?s lead program RINTEGA demonstrates overall survival benefit in patients with recurrent glio

E

EGBOT

Guest
Celldex?s lead program RINTEGA demonstrates overall survival benefit in patients with recurrent glioblastoma

HTML: 
Celldex Therapeutics, Inc. today presented positive results from the Company?s randomized, double?blind Phase 2 study of RINTEGA (rindopepimut) in patients with EGFRvIII?positive, recurrent glioblastoma at the 2015 American Society of Clinical Oncology in Chicago.

Source: Celldex?s lead program RINTEGA demonstrates overall survival benefit in patients with recurrent glioblastoma
 

Create an account or login to comment

You must be a member in order to leave a comment

Create account

Create an account on our community. It's easy!

Register

Log in

Already have an account? Log in here.

Latest threads

Back
Top